Exhibit 4.2
STOCK PURCHASE
AGREEMENT
STOCK PURCHASE
AGREEMENT (the “
Agreement ”), dated as of March 1, 2005 by and
among drugstore.com, inc., a Delaware corporation (the “
Company ”), and Ziff Asset Management, L.P. (the
“ Investor ”).
WHEREAS , the Company and the Investor are executing and
delivering this Agreement in reliance upon the exemption from
securities registration afforded by Section 4(2) of the
Securities Act of 1933, as amended (the “ Securities
Act ”), and Rule 506 of Regulation D (“
Regulation D ”) as promulgated by the United States
Securities and Exchange Commission (the “ Commission
”) under the Securities Act; and
WHEREAS , the Investor wishes to purchase, and the
Company wishes to sell, upon the terms and conditions stated in
this Agreement, 10,000,000 shares of the common stock, par value
$0.0001 per share, of the Company (the “ Common Stock
”). The shares of Common Stock to be purchased by the
Investor pursuant to this Agreement are referred to herein as the
“ Securities ”.
NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other
good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and the Investor agree as
follows:
ARTICLE I
DEFINITIONS
1.1 Definitions . In addition
to the terms defined elsewhere in this Agreement, the following
terms have the meanings indicated:
“ 13D Group ”
means any “group” (within the meaning of
Section 13(d) of the Exchange Act) formed for the purpose of
acquiring, holding, voting or disposing of Voting Securities of the
Company.
“ 2004 10-K ” has
the meaning set forth in Section 3.2(i) .
“ Advice ” has
the meaning set forth in Section 6.5 .
“ Affiliate ”
means, with respect to any Person, any other Person that, directly
or indirectly through one or more intermediaries,
“controls” or is “controlled” by or is
under common control with, such Person, as such terms are used in
and construed under Rule 144 under the Securities Act.
“ Agreement ” has
the meaning set forth in the Preamble.
“ Business Day ”
means any day other than Saturday, Sunday or other day on which
commercial banks in The City of New York are authorized or required
by law to remain closed.
“ Closing ” means
the closing of the purchase and sale of the Securities pursuant to
Section 2.1 .
“ Closing Date ”
means the date and time of the Closing and shall be 10:00 a.m., New
York City Time, on March 2, 2005 (or such other date and time
as is mutually agreed to by the Company and the
Investor).
“ Closing Price ”
means, for any date, the closing price per share of the Common
Stock for such date (or the nearest preceding date) on the primary
Eligible Market or exchange on which the Common Stock is then
listed or quoted.
“ Commission ”
has the meaning set forth in the Recitals.
“ Common Stock ”
has the meaning set forth in the Recitals.
“ Company ” has
the meaning set forth in the Preamble.
“ Company Counsel
” means Alesia L. Pinney, Vice President, General Counsel and
Secretary of the Company.
“ Disclosure Materials
” has the meaning set forth in Section 3.1(g)
.
“ Effective Date
” means the date that the Registration Statement is first
declared effective by the Commission.
“ Effectiveness Period
” has the meaning set forth in Section 6.1(b)
.
“ Election Period
” has the meaning set forth in Section 4.1(c)(ii)
.
“ Eligible Market
” means any of the New York Stock Exchange, the American
Stock Exchange, the Nasdaq National Market or the Nasdaq SmallCap
Market.
“ Exchange Act ”
means the Securities Exchange Act of 1934, as amended.
“ Fair Market Value
” means (i) with respect to cash consideration, the
total amount of such cash consideration in United States dollars,
(ii) with respect to non-cash consideration consisting of
publicly-traded securities, the average daily closing sales price
of such securities for the ten consecutive trading days preceding
the date the Fair Market Value of such securities is required to be
determined hereunder (with the closing price for each day being the
last reported sales price regular way or, in case no such reported
sale takes place on such day, the average of the reported closing
bid and asked prices regular way, in either case on the principal
national securities exchange on which such securities are listed
and admitted to trading, or, if not listed and admitted to trading
on any such exchange, on the Nasdaq National Market System, or if
not quoted on the Nasdaq National Market System, the average of the
closing bid and asked prices in the over-the-counter market as
furnished by any New York Stock Exchange member firm selected from
time to time by the Company for that purpose) and (iii) with
respect to non-cash consideration not consisting of publicly-traded
securities, such amount as is determined to be the fair market
value of the non-cash consideration as of the date such Fair Market
Value is required to be determined hereunder as determined in good
faith by the Investor.
For the purposes of
Section 4.1(c), if the Company disputes in good faith the
determination by the Investor pursuant to the above clause
(iii) of the Fair Market Value of the non-cash consideration
to be paid for the Restricted Securities, then the Company may
require that an investment bank selected by the Company and
reasonably acceptable to the Investor determine such Fair Market
Value for the purposes of clause (iii).
The Company shall pay the fees and
expenses of the investment bank in making any Fair Market Value
determination.
“ Indemnified Party
” has the meaning set forth in Section 6.4(c)
.
“ Indemnifying Party
” has the meaning set forth in Section 6.4(c)
.
“ Investor ” has
the meaning set forth in the Preamble.
“ Investor Counsel
” means Fried, Frank, Harris, Shriver & Jacobson
LLP, counsel to the Investor.
“ Lien ” means
any lien, charge, claim, security interest, encumbrance, right of
first refusal or other restriction.
“ Losses ” means
any and all losses, claims, damages, liabilities, settlement costs
and expenses, including, without limitation, costs of preparation
and reasonable attorneys’ fees.
“ Market Adjustment
” has the meaning set forth in
Section 4.1(c)(iii) .
2
“ Material Adverse
Effect ” has the meaning set forth in
Section 3.1(b) .
“ Offer Notice ”
has the meaning set forth in Section 4.1(c)(i)
.
“ Offer Price ”
has the meaning set forth in Section 4.1(c)(i)
.
“ Person ” means
any individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability
company, or joint stock company.
“ Proceeding ”
means an action, claim, suit, investigation or proceeding
(including, without limitation, an investigation or partial
proceeding, such as a deposition), whether commenced or threatened
in writing.
“ Prospectus ”
means the prospectus included in the Registration Statement at the
time of effectiveness (including, without limitation, a prospectus
that includes any information previously omitted from a prospectus
filed as part of an effective registration statement in reliance
upon Rule 430A promulgated under the Securities Act), as amended or
supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities
covered by the Registration Statement, and all other amendments and
supplements to such prospectus including post effective amendments,
and all material incorporated by reference or deemed to be
incorporated by reference in such prospectus.
“ Purchase Price
” means the Fair Market Value of the Transfer Consideration
paid by the Company or any of its Subsidiaries.
“ Regulation D ”
has the meaning set forth in the Recitals.
“ Registrable
Securities ” means any Securities issued pursuant to this
Agreement, together with any securities issued or issuable upon any
stock split, dividend or other distribution, recapitalization or
similar event with respect to the foregoing.
“ Registration
Statement ” means each registration statement required to
be filed under Article VI, as amended at the time and on the date
it became effective, including the information (if any) contained
in the form of final prospectus filed with the Commission pursuant
to Rule 424(b) or deemed to be part thereof at the time of
effectiveness pursuant to Rule 430A, and all material incorporated
by reference or deemed to be incorporated by reference in such
registration statement.
“ Repurchase Notice
” has the meaning set forth in Section 4.1(c)(ii)
.
“ Required Effectiveness
Date ” means the date on which the Restricted Period
ends.
“ Resale Price ”
has the meaning set forth in Section 4.1(c)(iii)
.
“ Restricted Period
” has the meaning set forth in Section 4.1(a)
.
“ Restricted Securities
” has the meaning set forth in Section 4.1(c)(i)
.
“ Rule 144 ,”
“ Rule 415 ,” “ Rule 424 ”
and “ Rule 430A ” means Rule 144, Rule 415, Rule
424 and Rule 430A, respectively, promulgated by the Commission
pursuant to the Securities Act, as such Rules may be amended from
time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same effect as such
Rule.
“ SEC Reports ”
has the meaning set forth in Section 3.1(g)
.
“ Securities ”
has the meaning set forth in the Recitals.
“ Securities Act
” has the meaning set forth in the Recitals.
3
“ Shares ” means
shares of the Company’s Common Stock.
“ Subsidiary ”
means any Person in which the Company, directly or indirectly, owns
Voting Securities having the power to elect a majority of the
directors (or similar members of such corporation’s or other
entity’s governing body), or otherwise direct the management
and polices of such corporation or other entity.
“ Tender Offer ”
shall mean a bona fide public offer subject to the provisions of
Regulation 13D or 14D under the Exchange Act, by a Person (which is
not made by and does not include the Investor, any Affiliates of
the Investor or any 13D Group that includes the Investor or any of
its Affiliates) to purchase or exchange for cash or other
consideration any Voting Securities of the Company; provided
that, for the purposes of this definition, in no event shall the
Company be considered an Affiliate of the Investor.
“ Trading Day ”
means (a) any day on which the Common Stock is listed or
quoted and traded on its primary Trading Market, (b) if the
Common Stock is not then listed or quoted and traded on any
Eligible Market, then a day on which trading occurs on the Nasdaq
National Market (or any successor thereto), or (c) if trading
ceases to occur on the Nasdaq National Market (or any successor
thereto), any Business Day.
“ Trading Market
” means the Nasdaq National Market or any other Eligible
Market, or any national securities exchange, market or trading or
quotation facility on which the Common Stock is then listed or
quoted.
“ Transfer ”
shall have the meaning set forth in Section 4.1(a)
.
“ Transfer Agent
” means Mellon Investor Services LLC or any successor
transfer agent for the Company.
“ Transfer
Consideration ” shall have the meaning set forth in
Section 4.1(c)(i) .
“ Transfer Offer
” shall have the meaning set forth in
Section 4.1(c)(i) .
“ Voting Securities
” shall mean stock or other equity securities of an entity
with the power to vote with respect to the election of directors
(or similar members of an entity’s governing body) generally
and shall include, in the case of a partnership or limited
liability company, a general partner, manager or managing member
interest, as applicable.
ARTICLE II
PURCHASE AND SALE
2.1 Closing . Subject to the
terms and conditions set forth in this Agreement, at the Closing
the Company shall issue and sell to the Investor, and the Investor
shall purchase from the Company, the Securities. The date and time
of the Closing and shall be 10:00 a.m., New York City Time, on the
Closing Date. The Closing shall take place at the offices of
Investor Counsel.
2.2 Closing Deliveries
.
(a) At the Closing, the Company
shall deliver or cause to be delivered to the Investor the
following:
(i) one or more stock certificates,
containing only the legends expressly provided in
Section 4.1(d) hereof, evidencing 10,000,000 Shares registered
in the name of the Investor; and
(ii) a legal opinion of Company
Counsel, in the form of Exhibit A , executed by such counsel
and delivered to the Investor.
(b) At the Closing, the Investor
shall deliver or cause to be delivered to the Company the aggregate
purchase price for the Securities, calculated by multiplying the
number of Securities
4
(10,000,000) by the greater of $2.60
or the Closing Price on the date of this Agreement, in United
States dollars and in immediately available funds, by wire transfer
to an account designated in writing to the Investor by the Company
for such purpose.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
3.1 Representations and
Warranties of the Company . The Company hereby represents and
warrants to the Investor as follows (which representations and
warranties shall be deemed to apply, where appropriate, to each
subsidiary of the Company):
(a) Subsidiaries . The
Company has no Subsidiaries or any other equity interests in any
other Person other than those listed in Schedule 3.1(a)
hereto. Except as disclosed in Schedule 3.1(a) hereto, the
Company owns, directly or indirectly, all of the capital stock or
comparable equity interests of each Subsidiary free and clear of
any Lien and all the issued and outstanding shares of capital stock
or comparable equity interests of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive
and similar rights.
(b) Organization and
Qualification . Each of the Company and the Subsidiaries is an
entity duly organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and
use its properties and assets and to carry on its business as
currently conducted. Neither the Company nor any Subsidiary is in
violation of any of the provisions of its respective certificate or
articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly
qualified to do business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, could not,
individually or in the aggregate, have a material adverse effect on
(i) the results of operations, assets, business or financial
condition of the Company and the Subsidiaries, taken as a whole on
a consolidated basis, or (ii) the Company’s ability to
consummate the transactions contemplated by this Agreement on a
timely basis (either of (i) or (ii), a “ Material
Adverse Effect ”).
(c) Authorization;
Enforcement . The Company has the requisite corporate authority
to enter into and to consummate the transactions contemplated by
this Agreement and otherwise to carry out its obligations
hereunder. The execution and delivery of this Agreement and the
consummation by it of the transactions contemplated hereby have
been duly authorized by all necessary action on the part of the
Company and no further consent or action is required by the
Company, its board of directors or its stockholders. This Agreement
has been (or upon delivery will be) duly executed by the Company
and is, or when delivered in accordance with the terms hereof, will
constitute, the valid and legally binding obligation of the Company
enforceable against the Company in accordance with its terms,
except as may be limited by applicable bankruptcy, insolvency,
reorganization or other laws of general application relating to or
affecting the enforcement of creditors rights generally, or by
general principles of equity.
(d) No Conflicts . The
execution, delivery and performance of this Agreement by the
Company and the consummation by the Company of the transactions
contemplated hereby and thereby do not, and will not,
(i) conflict with or violate any provision of the
Company’s Amended and Restated Certificate of Incorporation
or its bylaws, (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a
default) under, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice,
lapse of time or both) of, any agreement, credit facility, debt or
other instrument to which the Company or any Subsidiary is a party
or by which any property or asset of the Company or any Subsidiary
is bound, or affected, except to the extent that such conflict,
default, termination, amendment, acceleration or cancellation right
could not reasonably be expected to have a Material Adverse Effect,
or (iii) result in a violation of any law, rule, regulation,
order, judgment, injunction, decree
5
or other restriction of any court or
governmental authority to which the Company or a Subsidiary is
subject (including federal and state securities laws and
regulations and the rules and regulations of any self-regulatory
organization to which the Company or its securities are subject),
or by which any property or asset of the Company or a Subsidiary is
bound or affected, except to the extent that such violation could
not reasonably be expected to have a Material Adverse
Effect.
(e) Issuance of the
Securities . The Securities have been duly authorized and, when
issued and paid for in accordance with this Agreement, will be duly
and validly issued, fully paid and nonassessable, free and clear of
all Liens and shall not be subject to preemptive or similar rights
of stockholders.
(f) Capitalization . The
aggregate number of shares and type of all authorized, issued and
outstanding classes of capital stock, options and other securities
of the Company (whether or not presently convertible into or
exercisable or exchangeable for shares of capital stock of the
Company) as of the date of this Agreement is set forth in
Schedule 3.1(f) hereto. All outstanding shares of capital
stock are duly authorized, validly issued, fully paid and
nonassessable and have been issued in compliance with all
applicable securities laws. Except as disclosed in Schedule
3.1(f) hereto, the Company has not issued any other options,
warrants, script rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or
entered into any agreement giving any Person any right to subscribe
for or acquire, any shares of Common Stock, or securities or rights
convertible or exchangeable into shares of Common Stock. Except as
set forth on Schedule 3.1(f) hereto, and except for
customary adjustments as a result of stock dividends, stock splits,
combinations of shares, reorganizations, recapitalizations,
reclassifications or other similar events, there are no
anti-dilution or price adjustment provisions contained in any
security issued by the Company (or in any agreement providing
rights to security holders) and the issuance and sale of the
Securities will not obligate the Company to issue shares of Common
Stock or other securities to any Person (other than the Investor)
and will not result in a right of any holder of securities to
adjust the exercise, conversion, exchange or reset price under such
securities.
(g) SEC Reports; Financial
Statements . The Company has filed all reports required to be
filed by it under the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, for the twelve months
preceding the date hereof (the foregoing materials (together with
any materials filed by the Company under the Exchange Act, whether
or not required) being collectively referred to herein as the
“ SEC Reports ” and, together with this
Agreement and the Schedules to this Agreement, the “
Disclosure Materials ”) on a timely basis. The Company
has made available to the Investor or its representatives true,
correct and complete copies of the SEC Reports not available on the
EDGAR system. Except as disclosed on Schedule 3.1(g) , as of
the respective dates on which they were filed, the SEC Reports
complied in all material respects with the requirements of the
Securities Act and the Exchange Act and the rules and regulations
of the Commission promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading. Except as disclosed on Schedule 3.1(g) , the
audited consolidated balance sheets and audited consolidated
statements of income and cash flows of the Company as at
December 28, 2003 and December 29, 2002 and for the three
years ended December 28, 2003 and the unaudited consolidated
balance sheets and unaudited consolidated statements of income and
cash flows of the Company as at and for the periods ended
March 28, 2004, June 27, 2004 and September 26,
2004 (including in each case any related notes and schedules
thereto) included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at
the time of filing. Except as disclosed on Schedule 3.1(g) ,
such financial statements have been prepared in accordance with
United States generally accepted accounting principles (“
GAAP ”) applied on a consistent basis during the
periods involved, except as may be otherwise specified in such
financial statements or the notes thereto, and fairly present in
all material respects the consolidated
6
financial position of the Company
and its consolidated subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then
ended, subject, in the case of unaudited statements, to normal,
year-end audit adjustments. The Company has filed with the
Commission all material agreements required to be filed by the
Company, pursuant to Item 601 of Regulation S-K promulgated
under the Securities Act.
(h) Material Changes . Since
the date of the latest audited financial statements included within
the SEC Reports, and except as specifically disclosed in the SEC
Reports or in Schedule 3.1(h) hereto, (i) there has
been no event, occurrence or development that, individually or in
the aggregate, has had or that could result in a Material Adverse
Effect and (ii) the Company has not incurred any material
liabilities other than (A) trade payables and accrued expenses
incurred in the ordinary course of business consistent with past
practice and (B) liabilities not required to be reflected in
the Company’s financial statements pursuant to GAAP or
required to be disclosed in filings made with the
Commission.
(i) Absence of Litigation .
Except as disclosed in the Company’s SEC Reports, there is no
action, suit, claim, or proceeding, or, to the Company’s
knowledge, inquiry or investigation, before or by any court, public
board, government agency, self-regulatory organization or body
pending or, to the knowledge of the Company, threatened against or
affecting the Company or any of its Subsidiaries that would be
reasonably expected to, individually or in the aggregate, have a
Material Adverse Effect.
(j) Compliance . Neither the
Company nor any Subsidiary, except in each case as could not,
individually or in the aggregate, reasonably be expected to have or
result in a Material Adverse Effect, (i) is in default under
or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in
a default by the Company or any Subsidiary under), nor has the
Company or any Subsidiary received written notice of a claim that
it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or
instrument to which it is a party or by which it or any of its
properties is bound (whether or not such default or violation has
been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body, or (iii) is or has been in
violation of any statute, rule or regulation of any governmental
authority.
(k) No General Solicitation; No
Placement Agent . Neither the Company, nor any of its
Affiliates, nor any Person acting on its or their behalf, has
engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D) in connection with the offer
or sale of the Securities. The Company has not engaged any
placement agent or other agent in connection with the sale of the
Securities.
(l) Private Placement .
Neither the Company, nor any of its Affiliates, nor any Person
acting on the Company’s behalf, has, directly or indirectly,
at any time within the past six months, made any offer or sale of
any security or solicitation of any offer to buy any security under
circumstances that would (i) eliminate the availability of the
exemption from registration under Regulation D under the Securities
Act in connection with the offer and sale by the Company of the
Securities as contemplated hereby or (ii) cause the offering
of the Securities pursuant to this Agreement to be integrated with
prior offerings by the Company for purposes of any applicable law,
regulation or stockholder approval provisions, including, without
limitation, under the rules and regulations of any Trading
Market.
(m) Investment Company . The
Company is not, and is not an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of
1940, as amended.
(n) Real Property Holding
Company . The Company is not “a United States real
property holding corporation” within the meaning of the
Foreign Investment in Real Property Tax Act of 1980.
7
(o) Form S-3 Eligibility .
The Company is eligible to register the Securities for resale by
the Investor using Form S-3 promulgated under the Securities
Act.
(p) Listing and Maintenance
Requirements . The Company has not, in the twelve months
preceding the date hereof, received notice (written or oral) from
any Trading Market on which the Common Stock is or has been listed
or quoted to the effect that the Company is not in compliance with
the listing or maintenance requirements of such Trading Market. The
Company is in compliance with all such listing and maintenance
requirements.
(q) Registration Rights .
Except as described in Schedule 3.1(q) , the Company has not
granted or agreed to grant to any Person any rights (including
“piggy-back” registration rights) to have any
securities of the Company registered with the Commission or any
other governmental authority that have not been satisfied or
waived.
(r) Application of Takeover
Protections . There is no control share acquisition, business
combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the
Company’s charter documents or the laws of its state of
incorporation that is or could become applicable to the Investor as
a result of the Investor and the Company fulfilling their
obligations or exercising their rights under this Agreement,
including, without limitation, as a result of the Company’s
issuance of the Securities and the Investor’s ownership of
the Securities.
(s) Disclosure . The Company
confirms that neither it nor any officers, directors or Affiliates,
has provided the Investor or its agents or counsel with any
information that constitutes or might constitute material,
nonpublic information with respect to the Company (other than the
existence and terms of the issuance of Securities, as contemplated
by this Agreement, and the information disclosed on Schedule
3.1(g) ). The Company understands and confirms that the
Investor will rely on the foregoing representations in effecting
transactions in securities of the Company.
(t) Internal Accounting
Controls . Except as disclosed on Schedule 3.1(g) , the
Company and the Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally
accepted accounting principles and to maintain asset
accountability, (iii) access to assets is permitted only in
accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets
is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any
differences.
(u) Sarbanes-Oxley Act . The
Company is in compliance with applicable, effective requirements of
the Sarbanes-Oxley Act of 2002 and applicable, effective rules and
regulations promulgated by the Commission thereunder, except where
noncompliance therewith would not, individually or in the
aggregate, have a Material Adverse Effect.
3.2 Representations and
Warranties of the Investor . The Investor hereby represents and
warrants to the Company as follows:
(a) Organization; Authority .
The Investor is an entity duly organized, validly existing and in
good standing under the laws of the jurisdiction of its
organization with the requisite partnership power and authority to
enter into and to consummate the transactions contemplated by this
Agreement and otherwise to carry out its obligations hereunder. The
purchase by the Investor of the Securities hereunder has been duly
authorized by all necessary action on the part of the Investor.
This Agreement has been duly executed and delivered by the Investor
and constitutes the valid and legally binding obligation of the
Investor, enforceable against it in accordance with its terms,
except as may be limited by applicable bankruptcy,
8
insolvency, reorganization or other
laws of general application relating to or affecting the
enforcement of creditors rights generally, or by general principles
of equity.
(b) No Public Sale or
Distribution; Investment Intent . The Investor is acquiring the
Securities in the ordinary course of business for investment, for
its own account, and not with a view towards, or for resale in
connection with, the public sale or distribution thereof, except
pursuant to sales registered under the Securities Act or under an
exemption from such registration and in compliance with applicable
federal and state securities laws, and the Investor does not have a
present intention or arrangement to effect any sale or distribution
of the Securities to or through any person or entity, including,
without limitation, entering into any arrangement that transfers to
another, in whole or in part, any of the economic consequences of
ownership of the Securities, whether any such transaction is to be
settled by delivery of Common Stock or other securities, in cash or
otherwise; provided , however , that by making the
representations herein, the Investor does not agree to hold any of
the Securities for any minimum or other specific term and reserves
the right to dispose of the Securities at any time in accordance
with or pursuant to a registration statement or an exemption under
the Securities Act, subject, in each case, to the provisions of
Section 4.1 hereof.
(c) Investor Status . At the
time the Investor was offered the Securities, it was, and at the
date hereof it is, and at the Closing Date it will be, an
“accredited investor” as defined in Rule 501(a) under
the Securities Act.
(d) Experience of the
Investor . The Investor, either alone or together with its
representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating
the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such
investment. The Investor is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to
afford a complete loss of such investment.
(e) Access to Information .
The Investor acknowledges that it has reviewed the Disclosure
Materials and has been afforded: (i) the opportunity to ask
such questions as it has deemed necessary of, and to receive
answers from, representatives of the Company concerning the terms
and conditions of the offering of the Securities and the merits and
risks of investing in the Securities; (ii) access to
information (other than material non-public information) about the
Company and the Subsidiaries and their respective financial
condition, results of operations, business, properties, management
and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without
unreasonable effort or expense that is necessary to make an
informed investment decision with respect to the investment.
Neither such inquiries nor any other investigation conducted by or
on behalf of the Investor or its representatives or counsel shall
modify, amend or affect the Investor’s right to rely on the
truth, accuracy and completeness of the Disclosure Materials and
the Company’s representations and warranties contained in
this Agreement.
(f) No Governmental Review .
The Investor understands that no United States federal or state
agency or any other government or governmental agency has passed on
or made any recommendation or endorsement of the Securities or the
fairness or suitability of the investment in the Securities nor
have such authorities passed upon or endorsed the merits of the
offering of the Securities.
(g) No Conflicts . The
execution, delivery and performance by the Investor of this
Agreement and the consummation by the Investor of the transactions
contemplated hereby will not (i) conflict with or violate the
organizational documents of the Investor, (ii) conflict with,
or constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time, or both) of, any agreement,
credit facility, debt, indenture or other instrument to which the
Investor is a party or by which any of its property is bound,
or
9
(iii) result in a violation of any
law, rule, regulation, order, judgment, decree or other restriction
of any court or governmental authority to which the Investor is
subject (including federal and state securities laws) or by which
any of its property or assets is bound or affected, except in the
case of clauses (ii) and (iii) above, for such conflicts,
defaults or violations that are not material and do not otherwise
affect the ability of the Investor to consummate the transactions
contemplated hereby.
(h) No Legal, Tax or Investment
Advice . The Investor understands that nothing in this
Agreement or any other materials presented by or on behalf of the
Company to the Investor in connection with the purchase of the
Securities constitutes legal, tax or investment advice. The
Investor has consulted such legal, tax and investment advisors as
it, in its sole discretion, has deemed necessary or appropriate in
connection with its purchase of the Securities.
(i) Disclosure . The Investor
confirms that, to the Investor’s knowledge, none of the
Company and its officers, directors and Affiliates has provided the
Investor or its agents or counsel with any information that
constitutes or might constitute material, nonpublic information
with respect to the Company (other than the existence and terms of
the issuance of Securities, as contemplated by this Agreement, and
the information disclosed on Schedule 3.1(g) , which
information the Investor agrees to keep confidential until such
time as the Company’s annual report on Form 10-K for the
fiscal year ended January 2, 2005 (the “ 2004
10-K ”) is filed with the Commission).
ARTICLE IV
OTHER AGREEMENTS OF THE PARTIES
4.1 Transfer Restrictions
.
(a) The Investor covenants that it
will not, directly or indirectly sell, transfer or otherwise
dispose (including, without limitation, entering into any
arrangement that transfers to another, in whole or in part, any of
the economic consequences of ownership) (collectively, “
Transfer ”) of any Securities during the period
beginning on the Closing Date and ending on the one year
anniversary of the Closing Date (the “ Restricted
Period ”), except for any Transfer of Securities:
(i) to its Affiliates, provided that such Affiliates
deliver a written instrument to the Company, in form and substance
reasonably satisfactory to the Company, confirming that they are
subject to the obligations of the transferor under this Agreement,
(ii) which have been consented to in writing by the Company,
(iii) pursuant to a Tender Offer that, in the case of a third
party Tender Offer, is recommended by the board of directors of the
Company or (iv) to its equity holders, as part of a plan of
distribution to such equity holders, provided that such
equity holders deliver a written instrument to the Company, in form
and substance reasonably satisfactory to the Company, confirming
that they are subject to the obligations of this Agreement, and, in
each case, in accordance with the provisions of
Section 4.1(c).
(b) Following the end of the
Restricted Period, the Investor covenants that the Securities will
only be disposed of pursuant to an effective registration statement
under, and in compliance with the requirements of, the Securities
Act or pursuant to an available exemption from the registration
requirements of the Securities Act, and in compliance with any
applicable state securities laws, and, in each case, in accordance
with the provisions of Section 4.1(c). In connection with any
Transfer of Securities other than pursuant to an effective
registration statement or to the Company or pursuant to Rule
144(k), the Company requires the transferor to provide to the
Company an opinion of counsel selected by the transferor, the form
and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require
registration under the Securities Act.
(c) (i) If, following the end of the
Restricted Period, the Investor desires to Transfer any portion of
the Securities constituting 6% or more of the Voting Securities of
the Company outstanding on the date of such Transfer (the “
Restricted Securities ”) in a single transaction or
series of related transactions to a Person or 13D Group for their
own account (but excluding any
10
sale to a broker-dealer or market
maker, provided that such broker-dealer or market maker
sells such shares in substantially concurrent transactions to one
or more Persons and no such Person or Persons individually,
together with its or their Affiliates as applicable or as part of a
13D Group, purchases in such transactions Securities constituting
6% or more of the Voting Securities of the Company outstanding on
the date of such transactions), the Investor shall provide the
Company with a written notice (the “ Offer Notice
”) setting forth: (i) the number of shares of Common
Stock proposed to be Transferred and (ii) the material terms
and conditions of the proposed Transfer including the minimum price
(the “ Offer Price ”) at which the Investor
proposes to Transfer such shares (the “ Transfer Offer
”). The Offer Notice shall also constitute an irrevocable
offer to sell the Restricted Securities to the Company (x) at
the Offer Price and on the same terms and conditions as the
Transfer Offer or (y) if the Transfer Offer includes any
consideration other than cash, at the option of the Company, at a
cash price equal to the Fair Market Value of such non-cash
consideration (the “ Transfer Consideration
”).
(ii) If the Company wishes to accept
the offer set forth in the Offer Notice, the Company shall deliver
within three (3) Business Days of receipt of the Offer Notice
(such period, the “ Election Period ”) an
irrevocable notice of acceptance to the Investor (the “
Repurchase Notice ”), which Repurchase Notice shall
indicate that the Company agrees to purchase all of the Restricted
Securities specified in the Offer Notice and the form of Transfer
Consideration chosen (to the extent that the Transfer Offer
includes any consideration other than cash).
(iii) If the option to purchase the
Restricted Securities represented by the Offer Notice is accepted
on a timely basis by